The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1
暂无分享,去创建一个
[1] N. Fazilleau,et al. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Iijima,et al. Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells , 2001 .
[3] Raimund J. Ober,et al. Kinetics and thermodynamics of T cell receptor– autoantigen interactions in murine experimental autoimmune encephalomyelitis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Fersht,et al. Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] Alexis M. Kalergis,et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex , 2001, Nature Immunology.
[6] P. Kourilsky,et al. Role of the Complementarity-Determining Region 3 (CDR3) of the TCR-β Chains Associated with the Vα14 Semi-Invariant TCR α-Chain in the Selection of CD4+ NK T Cells1 , 2001, The Journal of Immunology.
[7] M. Kronenberg,et al. Presentation of self and microbial lipids by CD1 molecules. , 2001, Current opinion in immunology.
[8] A. Bendelac,et al. CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity , 2000 .
[9] M. Smyth,et al. NKT cells: facts, functions and fallacies. , 2000, Immunology today.
[10] M. Kronenberg,et al. Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.
[11] A. Cumano,et al. Evidence for Two Subgroups of CD4−CD8− NKT Cells with Distinct TCRαβ Repertoires and Differential Distribution in Lymphoid Tissues1 , 2000, The Journal of Immunology.
[12] I. Wilson,et al. Structural requirements for antigen presentation by mouse CD1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Kaer,et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α‐galactosylceramide , 2000, European journal of immunology.
[14] L. Teyton,et al. In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.
[15] H. Macdonald,et al. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells , 2000, European journal of immunology.
[16] A. Louise,et al. Liver CD4−CD8− NK1.1+ TCRαβ Intermediate Cells Increase During Experimental Malaria Infection and Are Able to Exhibit Inhibitory Activity Against the Parasite Liver Stage In Vitro1 , 2000, The Journal of Immunology.
[17] S. Jameson,et al. Critical Role for Cd8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers , 2000, The Journal of experimental medicine.
[18] Y. Chien,et al. A population of murine γδ T cells that recognize an inducible MHC class Ib molecule , 2000 .
[19] Y. Koezuka,et al. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. , 1999, Journal of immunology.
[20] M. Kronenberg,et al. Binding and Antigen Presentation of Ceramide-Containing Glycolipids by Soluble Mouse and Human Cd1d Molecules , 1999, The Journal of experimental medicine.
[21] B M Baker,et al. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.
[22] M. Kronenberg,et al. CD1-mediated immune responses to glycolipids. , 1999, Current opinion in immunology.
[23] M. Kronenberg,et al. Immunization with α‐galactosylceramide polarizes CD1‐reactive NK T cells towards Th2 cytokine synthesis , 1999, European journal of immunology.
[24] H. Iijima,et al. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules. , 1999, Journal of medicinal chemistry.
[25] M. Davis,et al. A kinetic basis for T cell receptor repertoire selection during an immune response. , 1999, Immunity.
[26] B K Jakobsen,et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. , 1999, Immunity.
[27] B K Jakobsen,et al. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.
[28] M. McConville,et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. , 1999, Science.
[29] M. Kronenberg,et al. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.
[30] M. Kronenberg,et al. Selective Ability of Mouse CD1 to Present Glycolipids: α-Galactosylceramide Specifically Stimulates Vα14+ NK T Lymphocytes , 1998, The Journal of Immunology.
[31] H. Macdonald,et al. Rapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice , 1998 .
[32] M. Alegre,et al. Tissue distribution, regulation and intracellular localization of murine CD1 molecules. , 1998, Molecular immunology.
[33] Y. Tanaka,et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Godfrey,et al. α/β–T Cell Receptor (TCR)+CD4−CD8− (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 , 1998, The Journal of experimental medicine.
[35] D. Hafler,et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.
[36] Hiroshi Sato,et al. Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .
[37] B. Reinhold,et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. , 1997, Science.
[38] M. Kronenberg,et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. , 1997, Journal of immunology.
[39] P. A. Peterson,et al. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. , 1997, Science.
[40] S. Kaufmann,et al. IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis. , 1997, Journal of immunology.
[41] S. Kaufmann,et al. Bacille Calmette Guérin and interleukin‐12 down‐modulate interleukin‐4‐producing CD4+ NK1+ T lymphocytes , 1997, European journal of immunology.
[42] P. A. Peterson,et al. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes , 1996, Nature.
[43] A. Herbelin,et al. Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse , 1996, European journal of immunology.
[44] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[45] A. Sher,et al. A Role for Cd4+nki.1 + T Lymphocytes as Major Histocompatibility Complex Class Ii Independent Helper Cells in the Generation of Cd8 + Effector Function against Intracellular Infection , 1996 .
[46] J. Yewdell,et al. CD1 recognition by mouse NK1+ T lymphocytes. , 1995, Science.
[47] R. Fisher,et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. , 1995, Science.
[48] P. Romero,et al. CD8 modulation of T-cell antigen receptor–ligand interactions on living cytotoxic T lymphocytes , 1995, Nature.
[49] M. Jackson,et al. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. J. Cohen,et al. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. , 1994, Immunity.
[51] L. Hood,et al. The human T-cell receptor TCRAC/TCRDC (C alpha/C delta) region: organization, sequence, and evolution of 97.6 kb of DNA. , 1994, Genomics.
[52] L. Hood,et al. Organization, structure, and function of 95 kb of DNA spanning the murine T-cell receptor CαCδ region , 1992 .
[53] P. Savage,et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d , 2002, Nature Immunology.
[54] L. Kaer,et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice , 2001, Nature Medicine.
[55] B. Malissen. Les liaisons dangereuses , 2001, Nature Immunology.
[56] Shane D. Marine,et al. T cell receptor binding kinetics and special role of Vα in T cell development and activation , 2000, Immunologic research.
[57] S. Porcelli,et al. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.
[58] Mark M. Davis,et al. LIGAND RECOGNITION BY T CELL RECEPTORS , 1998 .
[59] Z Reich,et al. Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.